Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
All >

News > Switzerland

Total search results: 1116 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. 2021-04-07
ADC Therapeutics S.A.. (4/6/21). "Press Release: Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer". Boston, MA, Shanghai & Lausanne. 2021-04-06
Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich. 2021-03-24
Evolva S.A.. (3/24/21). "Press Release: Evolva Announces New Chief Financial Officer". Reinach. 2021-03-24
Novartis AG. (3/22/21). "Press Release: Novartis Appoints Karen Hale as Chief Legal Officer". Basel. 2021-03-22
Relief Therapeutics Holding AG. (3/22/21). "Press Release: Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine D 2021-03-22
Nordic Nanovector ASA. (3/18/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer". Potsdam & Berlin. 2021-03-18
Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg. 2021-03-18
Aktis Oncology. (3/18/21). "Press Release: Aktis Oncology Announces $72m Series A Financing to Advance Breakthrought Radiopharmaceuticals to Treat Solid Tumors". Cambridge, MA. 2021-03-18
Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva. 2021-03-18
Relief Therapeutics Holding AG. (3/12/21). "Press Release: Relief Announces CHF 10 Million Private Placement". Geneva. 2021-03-12
Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel. 2021-02-26
Celonic AG. (2/25/21). "Press Release: Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland". Basel. 2021-02-25
Enamine Ltd.. (2/24/21). "Press Release: Enamine Extend Collaboration with Prominent Swiss Biotech". Kyiv. 2021-02-24
Minaris Regnerative Medicine GmbH. (2/22/21). "Press Release: MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy". Geneva & Munich. 2021-02-22
Biomunex Pharmaceuticals SASU. (2/16/21). "Press Release: Biomunex Pharmaceuticals Signs Strategic License and Co-Development Agreement with Onward Therapeutics for Proprietary Bispecific Antibody Program". Paris & Cambridge, MA. 2021-02-16
Sophia Genetics S.A.. (2/11/21). "Press Release: Sophia Genetics Appoints Ross Muken as Chief Financial Officer". Boston, MA & Lausanne. 2021-02-11
Tecan Group Ltd.. (2/4/21). "Press Release: Tecan and UgenTec Partner to Offer Sample-to-result Solutions for qPCR". Männedorf. 2021-02-04
CRISPR Therapeutics AG. (2/1/21). "Press Release: CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer". Zug & Cambridge, MA. 2021-02-01
Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan. 2021-01-28
Microcaps AG. (1/26/21). "Press Release: Microcaps Closes CHF 5 Million Seed Financing Round Co-led by Helvetica Capital and Zürcher Kantonalbank". Zurich. 2021-01-26
Cellvie Inc.. (1/25/21). "Press Release: Harvard Spin-off Cellvie Closes $5M Seed Round in Pursuit of a New Treatment Modality – Therapeutic Mitochondria Transfer". Zurich & Houston, TX. 2021-01-25
Numares AG. (1/21/21). "Press Release: Numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics". Boston, MA & Regensburg. 2021-01-21
Relief Therapeutics Holding AG. (1/20/21). "Press Release: Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil". Geneva & Gundelfingen. 2021-01-20
Sophia Genetics S.A.. (1/19/21). "Press Release: Sophia Genetics Appoints Influential Regulatory Figure Kathy L. Hibbs to Board of Directors". Boston, MA & Lausanne. 2021-01-19
Sophia Genetics S.A.. (1/19/21). "Press Release: Sophia Genetics and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer". Boston, MA & Lausanne. 2021-01-19
Lonza Group AG. (1/19/21). "Press Release: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms". Basel & London. 2021-01-19
Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA. 2021-01-15
IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen. 2021-01-13
Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden. 2021-01-12
Labforward GmbH. (1/11/21). "Press Release: Laboratory SaaS provider Labforward Closes Series-B". Berlin. 2021-01-11
Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. 2021-01-11
Tecan Group Ltd.. (1/11/21). "Press Release: Tecan Invests in Labforward to further Drive Lab Digitalization". Männedorf. 2021-01-11
Addex Therapeutics S.A.. (1/11/21). "Press Release: Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities". Geneva. 2021-01-11
Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. 2021-01-08
Ribometrix, Inc.. (1/6/21). "Press Release: Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics". Durham, NC. 2021-01-06
Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. 2021-01-04
BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz. 2020-12-19
SGS S.A.. (12/18/20). "Press Release: SGS Ends Share Buyback Program". 2020-12-18
Cadent Therapeutics. (12/17/20). "Press Release: Cadent Therapeutics Enters Agreement to Be Acquired by Novartis". Cambridge, MA. 2020-12-17
Novartis AG. (12/17/20). "Press Release: Novartis Builds on Commitment to Addressing Need in Neuropsychiatric Disorders with Cadent Therapeutics Acquisition". Basel. 2020-12-17
ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Welcomes Nestlé as an Investor to Accelerate Sustainable Innovation in Europe". Luxembourg. 2020-12-15
ECBF Management GmbH. (12/15/20). "Press Release: The European Circular Bioeconomy Fund Has Raised €175 Million to Foster Sustainable Innovations". Luxembourg. 2020-12-15
ADC Therapeutics S.A.. (12/14/20). "Press Release: ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China 2020-12-14
Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel. 2020-12-11
Boehringer Ingelheim. (12/10/20). "Press Release: Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates". Ingelheim & Basel. 2020-12-10
RetinAI Medical AG. (12/8/20). "Press Release: RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology". Bern. 2020-12-08
Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich). 2020-11-25
Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris. 2020-11-23
Novartis AG. (11/19/20). "Press Release: Novartis Secures Exclusive Rights for Potential Acute Respiratory Distress Syndrome Cell Therapy". Basel. 2020-11-19
Lino Biotech AG. (11/17/20). "Press Release: Lino Biotech Closes Seed Financing Round and Showcases a Novel Label-free Biosensor Platform for Innovate Modern Drug Screening". Zurich. 2020-11-17
Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases". 2020-11-16
Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel. 2020-11-12
Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. 2020-11-09
Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt. 2020-11-09
Memo Therapeutics AG. (11/5/20). "Press Release: Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round". Schlieren. 2020-11-05
Novartis AG. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness". Basel. 2020-10-29
CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA. 2020-10-28
Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin. 2020-10-27
NBE Therapeutics AG. (10/26/20). "Press Release: NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors". Basel. 2020-10-26
Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. 2020-10-22
Araris Biotech AG. (10/22/20). "Press Release: Araris Biotech Completes CHF 15.2 Million Seed Financing Round". Zürich. 2020-10-22
Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA. 2020-10-20
Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT. 2020-10-20
Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. 2020-10-20
Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva. 2020-10-16
VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. 2020-10-15
Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. 2020-10-14
Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. 2020-10-13
Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". 2020-10-13
Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. 2020-10-13
Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. 2020-10-09
Relief Therapeutics Holding AG. (10/8/20). "Press Release: Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer". Geneva. 2020-10-08
Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt. 2020-10-06
Santhera Pharmaceuticals Holding AG. (10/6/20). "Press Release: Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone". Pratteln. 2020-10-06
Sophia Genetics S.A.. (10/1/20). "Press Release: Sophia Genetics Raises $110 Million in Oversubscribed New Funding Round". Lausanne & Boston, MA. 2020-10-01
Numab Therapeutics AG. (9/30/20). "Press Release: Numab Therapeutics Appoints Daniel Vasella as New Chairman of the Board". Wädenswil (Zurich). 2020-09-30
BaseLaunch (BaselArea.swiss). (9/28/20). "Press Release: BaseLaunch Announces that Johnson & Johnson Innovation Has Renewed Its Commitment Becoming Latest Strategic Partner in the Second Phase". Basel. 2020-09-28
BB Pureos Bioventures. (9/23/20). "Press Release: Pureos Bioventures Closes First Fund with USD 170 Million". St. Peter Port, Guernsey & Küsnacht. 2020-09-23
Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge. 2020-09-21
NovaGo Therapeutics AG. (9/21/20). "Press Release: NovaGo Therapeutics Appoints Ian Metcalfe as CEO". Schlieren. 2020-09-21
Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel. 2020-09-16
Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. 2020-09-16
Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. 2020-09-16
Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. 2020-09-08
NBE Therapeutics AG. (9/8/20). "Press Release: Exelixis and NBE-Therapeutics Enter into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer". Alameda, CA & Basel. 2020-09-08
Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. 2020-09-07
EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". 2020-09-03
BioVersys AG. (9/1/20). "Press Release: BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development". Basel. 2020-09-01
Oculis S.A.. (9/1/20). "Press Release: Oculis Establishes Presence in U.S. and Appoints Sylvia Cheung as Chief Financial Officer". Lausanne. 2020-09-01
Aimmune Therapeutics, Inc.. (8/31/20). "Press Release: Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science". Brisbane, CA. 2020-08-31
Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". 2020-08-31
Addex Therapeutics S.A.. (8/27/20). "Press Release: Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Modelling". Geneva. 2020-08-27
NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. 2020-08-10
T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. 2020-08-06
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. 2020-08-05
Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. 2020-08-05
GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl 2020-08-05
NBE Therapeutics AG. (8/3/20). "Press Release: NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer". Basel. 2020-08-03
PharmaLex GmbH. (8/1/20). "Press Release: PharmaLex Strengthens Its Commercial Organization". Frankfurt. 2020-08-01
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] No Content Marketing 650x80px

» top